Engineering peptide inhibitors to overcome PDZ binding promiscuity.
作者信息
Vouilleme Lars, Cushing Patrick R, Volkmer Rudolf, Madden Dean R, Boisguerin Prisca
机构信息
Institute of Medical Immunology, Charité-Universitätsmedizin Berlin, Hessische Strasse 3-4, 10115 Berlin, Germany.
出版信息
Angew Chem Int Ed Engl. 2010 Dec 17;49(51):9912-6. doi: 10.1002/anie.201005575.
Abstract
摘要
相似文献
1
Engineering peptide inhibitors to overcome PDZ binding promiscuity.
Angew Chem Int Ed Engl. 2010 Dec 17;49(51):9912-6. doi: 10.1002/anie.201005575.
2
Hybrid organic-inorganic inhibitors of a PDZ interaction that regulates the endocytic fate of CFTR.
Angew Chem Int Ed Engl. 2012 Jul 16;51(29):7217-20. doi: 10.1002/anie.201202291. Epub 2012 Jun 14.
3
Stereochemical preferences modulate affinity and selectivity among five PDZ domains that bind CFTR: comparative structural and sequence analyses.
Structure. 2014 Jan 7;22(1):82-93. doi: 10.1016/j.str.2013.09.019. Epub 2013 Nov 7.
4
A Golgi-associated PDZ domain protein modulates cystic fibrosis transmembrane regulator plasma membrane expression.
J Biol Chem. 2002 Feb 1;277(5):3520-9. doi: 10.1074/jbc.M110177200. Epub 2001 Nov 13.
5
Cysteine modifiers suggest an allosteric inhibitory site on the CAL PDZ domain.
Biosci Rep. 2018 Jul 6;38(4). doi: 10.1042/BSR20180231. Print 2018 Aug 31.
6
Interaction with cystic fibrosis transmembrane conductance regulator-associated ligand (CAL) inhibits beta1-adrenergic receptor surface expression.
J Biol Chem. 2004 Nov 26;279(48):50190-6. doi: 10.1074/jbc.M404876200. Epub 2004 Sep 9.
7
Computational design of a PDZ domain peptide inhibitor that rescues CFTR activity.
PLoS Comput Biol. 2012;8(4):e1002477. doi: 10.1371/journal.pcbi.1002477. Epub 2012 Apr 19.
8
The relative binding affinities of PDZ partners for CFTR: a biochemical basis for efficient endocytic recycling.
Biochemistry. 2008 Sep 23;47(38):10084-98. doi: 10.1021/bi8003928. Epub 2008 Aug 29.
9
Ubiquitination and degradation of CFTR by the E3 ubiquitin ligase MARCH2 through its association with adaptor proteins CAL and STX6.
PLoS One. 2013 Jun 20;8(6):e68001. doi: 10.1371/journal.pone.0068001. Print 2013.
10
CFTR anion channel modulates expression of human transmembrane mucin MUC3 through the PDZ protein GOPC.
J Cell Sci. 2011 Sep 15;124(Pt 18):3074-83. doi: 10.1242/jcs.076943. Epub 2011 Aug 18.
引用本文的文献
1
The conformation of the nSrc specificity-determining loop in the Src SH3 domain is modulated by a WX conserved sequence motif found in SH3 domains.
Front Mol Biosci. 2024 Dec 3;11:1487276. doi: 10.3389/fmolb.2024.1487276. eCollection 2024.
2
GOPC facilitates the sorting of syndecan-1 in polarized epithelial cells.
Mol Biol Cell. 2022 Sep 1;33(10):ar86. doi: 10.1091/mbc.E22-05-0165. Epub 2022 Jul 13.
3
Highway to Cell: Selection of the Best Cell-Penetrating Peptide to Internalize the CFTR-Stabilizing iCAL36 Peptide.
Pharmaceutics. 2022 Apr 7;14(4):808. doi: 10.3390/pharmaceutics14040808.
4
Proteostasis Regulators in Cystic Fibrosis: Current Development and Future Perspectives.
J Med Chem. 2022 Apr 14;65(7):5212-5243. doi: 10.1021/acs.jmedchem.1c01897. Epub 2022 Apr 4.
5
Systematic Modeling, Prediction, and Comparison of Domain-Peptide Affinities: Does it Work Effectively With the Peptide QSAR Methodology?
Front Genet. 2022 Jan 14;12:800857. doi: 10.3389/fgene.2021.800857. eCollection 2021.
6
Targeting PDZ domains as potential treatment for viral infections, neurodegeneration and cancer.
Biol Direct. 2021 Oct 12;16(1):15. doi: 10.1186/s13062-021-00303-9.
7
Domain Analysis and Motif Matcher (DAMM): A Program to Predict Selectivity Determinants in PDZ Domains Using Human PDZ Data.
Molecules. 2021 Oct 5;26(19):6034. doi: 10.3390/molecules26196034.
8
Interactomic affinity profiling by holdup assay: Acetylation and distal residues impact the PDZome-binding specificity of PTEN phosphatase.
PLoS One. 2020 Dec 31;15(12):e0244613. doi: 10.1371/journal.pone.0244613. eCollection 2020.
9
Cyclic Peptidyl Inhibitors against CAL/CFTR Interaction for Treatment of Cystic Fibrosis.
J Med Chem. 2020 Dec 24;63(24):15773-15784. doi: 10.1021/acs.jmedchem.0c01528. Epub 2020 Dec 14.
10
Structural characterization and computational analysis of PDZ domains in Monosiga brevicollis.
Protein Sci. 2020 Nov;29(11):2226-2244. doi: 10.1002/pro.3947. Epub 2020 Sep 25.
本文引用的文献
1
A stabilizing influence: CAL PDZ inhibition extends the half-life of ΔF508-CFTR.
Angew Chem Int Ed Engl. 2010 Dec 17;49(51):9907-11. doi: 10.1002/anie.201005585.
2
Synthesis and application of peptide arrays: quo vadis SPOT technology.
Chembiochem. 2009 Jun 15;10(9):1431-42. doi: 10.1002/cbic.200900078.
3
Design of protein-interaction specificity gives selective bZIP-binding peptides.
Nature. 2009 Apr 16;458(7240):859-64. doi: 10.1038/nature07885.
4
A specificity map for the PDZ domain family.
PLoS Biol. 2008 Sep 30;6(9):e239. doi: 10.1371/journal.pbio.0060239.
5
The relative binding affinities of PDZ partners for CFTR: a biochemical basis for efficient endocytic recycling.
Biochemistry. 2008 Sep 23;47(38):10084-98. doi: 10.1021/bi8003928. Epub 2008 Aug 29.
6
Synthesis and screening of support-bound combinatorial peptide libraries with free C-termini: determination of the sequence specificity of PDZ domains.
Biochemistry. 2008 Mar 4;47(9):3061-72. doi: 10.1021/bi7023628. Epub 2008 Jan 31.
7
Rational design of the first small-molecule antagonists of NHERF1/EBP50 PDZ domains.
Bioorg Med Chem Lett. 2008 Feb 1;18(3):942-5. doi: 10.1016/j.bmcl.2007.12.038. Epub 2007 Dec 23.
8
Characterization of a putative phosphorylation switch: adaptation of SPOT synthesis to analyze PDZ domain regulation mechanisms.
Chembiochem. 2007 Dec 17;8(18):2302-7. doi: 10.1002/cbic.200700518.
9
PDZ domain binding selectivity is optimized across the mouse proteome.
Science. 2007 Jul 20;317(5836):364-9. doi: 10.1126/science.1144592.
10
NHE3 inhibits PKA-dependent functional expression of CFTR by NHERF2 PDZ interactions.
Biochem Biophys Res Commun. 2006 Aug 25;347(2):452-9. doi: 10.1016/j.bbrc.2006.06.112. Epub 2006 Jun 28.
Zotero 插件